Showing results (281-290 of 328) with videos related to
Sort By:
Pageof 33
Scandinavian Journal of Immunology|June 18, 2016
Association of Low Ficolin-Lectin Pathway Parameters with Cardiac Syndrome XZ Horváth, D Csuka, K Vargova, et al.Allergy|September 5, 2014
A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymesK Joseph, S Bains, B G Tholanikunnel, et al.Proceedings of the National Academy of Sciences of the United States of America|February 3, 2004
Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10Jozsef L Varga, Andrew V Schally, Judit E Horvath, et al.Neurogastroenterology and Motility|October 3, 2002
Influence of naloxone on gastric emptying of solid meals, myoelectrical gastric activity and blood hormone levels in young healthy volunteersP U Reber, P Netzer, C Gaia, et al.Seminars in Cancer Biology|July 11, 2000
H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cellsZ Radvány, Z Darvas, K Kerekes, et al.Journal of Peptide Science : an Official Publication of the European Peptide Society|September 1, 1995
Synthesis and bioactivity studies of 1-adamantanamine derivatives of peptidesS Horvat, L Varga-Defterdarović, J Horvat, et al.Journal of Cognitive Neuroscience|January 10, 2025
Differentiation of Related Events in Hippocampus Supports Memory Reinstatement in DevelopmentNicole L Varga, Hannah E Roome, Robert J Molitor, et al.Cancer Research|November 25, 2003
Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinomaZoltan Szereday, Andrew V Schally, Jozsef L Varga, et al.European Journal of Cancer (Oxford, England : 1990)|November 18, 2005
Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signallingAnton Stangelberger, Andrew V Schally, Jozsef L Varga, et al.The Prostate|August 30, 2008
Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138Elmar Heinrich, Andrew V Schally, Stefan Buchholz, et al.Pageof 33